The PennZone

  • Home
  • Business
  • Non-profit
  • Health
  • Technology
  • Travel
  • Real Estate
  • Services
  • Construction

Nattokinase Supplement for Cardiovascular and Circulatory Support
The PennZone/10270754

Trending...
  • Mend Colorado Launches Revamped Sports Performance Training Page
  • OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors
  • Authoress S.E. Gregg Offers Gold-Signed Copies in 2026"
Nattokinase Heart Health Supplement
AgeImmune's Nattokinase is one of the purest professional grade supplement on the market which is beneficial for overall heart health.

NEW YORK - PennZone -- Dr. Kanevsky, D.C. C.F.M.P. introduced a new supplement to AgeImmune's product line
earlier this May 2024.
A new addition to the family is Nattokinase supplement in a form of a vegetable capsule
each containing 2,000FU (fibrin unit) representing a unit of potency, which is equal to
100mg. Dr. Kanevsky is recommending a serving size of 2 capsules. However, if you
are in excellent heart health with no family history of blood clots, 1 capsule is enough as
a preventative measure.
Nattokinase is an enzyme derived from Japanese soybean called Natto via fermentation
process with a bacteria called Bacillus subtilis. Natto has been consumed as a
traditional food in Asia for over 2000 years and is believed to be a significant contributor

More on The PennZone
  • Angels Of Dirt Premieres on Youtube, Announces Paige Keck Helmet Sponsorship for 2026 Season
  • "They Said It Was Impossible": This Bottle Turns Any Freshwater Source Into Ice-Cold, Purified Drinking Water in Seconds
  • Patron Saints Of Music Names Allie Moskovits Head Of Sync & Business Development
  • Dave Aronberg Named 2026 John C. Randolph Award Recipient by Palm Beach Fellowship of Christians & Jews
  • General Relativity Challenged by New Tension Discovered in Dark Siren Cosmology

to the longevity of the Japanese people. Although natto has been consumed in Asia for
thousands of years, the fibrinolytic and antithrombolytic property of Nattokinasae was
only discovered in 1987. Recent studies demonstrated that high natto intake is
associated with decreased risk of cardiovascular disease.
This was a sufficient reason for Dr. Kanevsky to add Nattokinase to his line of products.
There is some early evidence that nattokinase may thin the blood and help break up
blood clots. This might protect against heart disease and conditions caused by blood
clots such as stroke, heart attack, and others.
Other studies show that nattokinase may help lower blood pressure and reduce
inflammation in the body.
Unlike traditional blood thinning medications, nattokinase is a natural, widely available
and inexpensive supplement with minimal to no side effects which makes is very

More on The PennZone
  • Burkentine Real Estate Group to Bring A New Community to Millersville, Pennsylvania
  • Unseasonable Warmth Triggers Early Pest Season Along I-5 Corridor
  • VIP Vacations Named Winner in 2026 WeddingWire Couples' Choice Awards®
  • Colonial Nissan Champions Community Service and Trust Across the Greater Philadelphia Region
  • Bug Busters Expands Service Footprint With New Carrollton, Georgia Branch

attractive to Dr. Kanevsky's patients searching for an all-natural approach to their
health.
Having a large database of functional medicine patients Dr Kanevsky easily analyzed
the frequency of complains of a poor heart health, circulation, blood pressure and came
to a conclusion that Nattokinase will become one of the most popular products for
AgeImmune.
As always encapsulated without harmful excipients such as magnesium stearate, silicon
dioxide or titanium dioxide, AgeImmune's Nattokinase is one of the purest professional
grade supplement on the market.
Nattokinase supplement is derived from soy. Dr. Kanevsky warns that if you are allergic
to soy, you shouldn't be taking Nattokinase. It is currently available for purchase at a
discounted price of 21.99 on AgeImmune's website and on Amazon

Contact
AgeImmine
***@netembark.com


Source: Nattokinase Heart Health Supplement

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Patent Bar Exam Candidates Achieve 30% Higher Pass Rates with Wysebridge's 2026 Platform
  • Municipal Carbon Field Guide Launched by LandConnect -- New Revenue Streams for Cities Managing Vacant Land
  • Hoy Law Wins Supreme Court Decision Establishing Federal Trucking Regulations as the Standard of Care in South Dakota
  • Dr. Rashad Richey's Indisputable Shatters Records, Over 1 Billion YouTube Views, Top 1% Podcast, 3.2 Million Viewers Daily
  • Lee, Miller, Quesada Featured in Standout FAN EXPO Philadelphia Creator Lineup, May 29-31
  • Grand Opening: New Single-Family Homes Now Open for Sale at Heritage at Manalapan
  • Radiant Floor Heating & Tile: Why More Chester County Homeowners Are Choosing Comfort Over Convention
  • Shelter Structures America Announces Distribution Partnership with The DuraTrac Group
  • The OpenSSL Corporation Releases Its Annual Report 2025
  • Iranian-Born Engineer Mohsen Bahmani Introduces Propeller-Less Propulsion for Urban Air Mobility
  • Aleen Inc. (C S E: ALEN.U) Advances Digital Wellness Vision with Streamlined Platform Navigation and Long-Term Growth Strategy
  • RimbaMindaAI Officially Launches Version 3.0 Following Strategic Breakthrough in Malaysian Market Analysis
  • Fed Rate Pause & Dow 50k: Irfan Zuyrel on Liquidity Shifts, Crypto Volatility, and the ASEAN Opportunity
  • 20/20 Institute Launches Updated Vision Correction Procedures Page for Denver & Colorado Springs
  • OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors
  • New Children's Picture Book "Diwa of Mount Luntian" Focuses on Calm, Culture, and Connection for Today's Families
  • Actor, Spokesperson Rio Rocket Featured in "Switch to AT&T" Campaign Showing How Customers Can BYOD and Keep Their Number
  • The World's No.1 Superstar® Brings Disco Fever Back With New Global Single and Video "Disco Dancing"
  • Boston Industrial Solutions' Natron® 512N Series UV LED Ink Achieves BPA Certification, Advancing Safe and Sustainable Digital Printing
  • Joan Nissen promoted to Century Fasteners Corp. – General Manager, Aerospace & Government Sales

Popular on PennZone

  • Mark Schork Selected As 'Board Observer' By Philadelphia Bar Foundation - 158
  • Michael Judkins Releases New Poetry Book, Deeper Than You Think
  • Reputation Management Services Expanded
  • $80 Million Revenue Backlog for AI Cybersecurity Company Building the Future of Integrated Cybersecurity and Public Safety: $CYCU
  • Precision Adult Care Expands 24/7 Adult In-Home Care Services to Meet Growing Demand in the Coachella Valley
  • Secondesk Launches Powerful AI Tutor That Speaks 20+ Languages
  • Steve Everett Jr. Named President of L.T. Hampel Corporation
  • $26 Billion Global Market by 2035 for Digital Assets Opens Major Potential for Currency Tech Company with ATM Expansion and Deployment Plans Underway
  • A High-Velocity Growth Story Emerges in Marine and Luxury Markets
  • Peernovation 365 is Now Available

Similar on PennZone

  • Amy Turner Receives 2025 ENPY Partnership Builder Award from The Community Foundation
  • "They Said It Was Impossible": This Bottle Turns Any Freshwater Source Into Ice-Cold, Purified Drinking Water in Seconds
  • Excel Signworks Introduces Custom Lobby Signs to Help Pittsburgh Businesses Elevate First Impressions in 2026
  • Deep Learning Robotics (DLRob) Announces Pre-Launch of Zero-Teach and Teach-by-Demonstration Technology for Kitting Applications
  • Aleen Inc. (C S E: ALEN.U) Advances Digital Wellness Vision with Streamlined Platform Navigation and Long-Term Growth Strategy
  • 20/20 Institute Launches Updated Vision Correction Procedures Page for Denver & Colorado Springs
  • NRE-HEALTH Radio Launches With a New Approach to Health Broadcasting
  • From Coffee to Commutes: sMiles App Now Pays Bitcoin for Every Gift Card Purchase
  • Dr. Billy B. Laun II Addresses Over 120 Dental Professionals at Annual Dental Meeting
  • CCHR: Taxpayer Billions Wasted on Mental Health Research as Outcomes Deteriorate
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us